Perioperative medicine & outcomes

Functional impairment in patients undergoing major orthopaedic surgery under general anaesthesia with or without regional anaesthesia: a target trial emulation using a national hospital claims database

Br J AnaesthPublished Target trial emulation using a national hospital claims database

Main findingResult — go to the resultMean difference 0.73 95% CI 0.57–0.88

Authors' conclusion

Combined general and regional anaesthesia was associated clinically with modest improvements in discharge-anchored functional change, postoperative stay and in-hospital mortality.

Study context

Population
Adults undergoing major orthopaedic surgery, Japanese Diagnosis Procedure Combination database, April 1, 2016-December 31, 2023
Participants
244,212 vs 435,462
Exposure
GA+RA vs GA alone
  • GA+RAn = 244,212
  • GA alonen = 435,462reference
Outcome
Discharge-anchored functional change (difference in Barthel Index scores between admission and discharge)
Follow-up
Discharge
Methodological detailsstabilised inverse probability of treatment weighting, multiple imputation
  • Stabilised inverse probability of treatment weighting
  • Multiple imputation

Main finding

As reported in the abstract

Mean difference

0.73

95% CI 0.57–0.88

P < 0.001

GA+RA vs GA alone
mean difference 0.73 (95% CI 0.57–0.88); P < 0.001

Observational data: associations, not effects.

Secondary outcomes

OutcomeDifference (days) (95% CI)P value
Postoperative LOS−1.40 (−1.45 to −1.35)P < 0.001
OutcomeHR (95% CI)P value
In-hospital mortality0.85 (0.76–0.96)P = 0.006

Sensitivity analyses

Directionally consistent findings

Original publication

Functional impairment in patients undergoing major orthopaedic surgery under general anaesthesia with or without regional anaesthesia: a target trial emulation using a national hospital claims database. Br J Anaesth. Published 17 July 2026. doi:10.1016/j.bja.2026.06.008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.